Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Acetic Acid | HCID 176 | — |
| Reactant | Formaldehyde | HCID 712 | — |
| Reactant | Sodium triacetoxyborohydride | HCID 5049666 | — |
| Reactant | HCID 57957908 | HCID 57957908 | — |
| Solvent | 1,1-Dichloroethane | HCID 6365 | — |
| Product | HCID 136017418 | HCID 136017418 | — |
Reaction Steps
Treatment of 2-(5-amino-3-bromo-4-nitro-1H-pyrazol-1-yl)ethanol 1 with paraformaldehyde and sodium triacetoxyborohydride in dichloroethane containing acetic acid affords 8-bromo-9-nitro-1,2,4,5-tetrahydropyrazolo[5,1-d][1,3,5]oxadiazepine 2. The reaction of the compound 2 with KOH in the presence of Pd2dba3 and 2-di-tert-butylphosphino-2′,4′,6′-triisopropylbiphenyl in 1,4-dioxane, water provides 9-nitro-1,2,4,5-tetrahydropyrazolo[5,1-d][1,3,5]oxadiazepin-8-ol 3, which upon treatment with MeI and cetylammonium bromide in 1,4-dioxane/water/KOH affords compound 8-methoxy-9-nitro-1,2,4,5-tetrahydropyrazolo[5,1-d][1,3,5]oxadiazepine 4 (J. Am. Chem. Soc. 2006, 128, 10694). Hydrogenation of 4 with Pd/C at 60 psi of hydrogen yields 8-methoxy-1,2,4,5-tetrahydropyrazolo[5,1-d][1,3,5]oxadiazepin-9-amine 5.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07850742B2 |
|---|
| Source dataset | uspto-grants-2010_12 |
|---|
| ORD ID | ord-a1c0bee3490f40f490016250cdeb5392 |
|---|
| Source note | uspto-grants-2010_12 |
|---|